THE ROLE OF BIOMARKERS IN THE MODERN DIAGNOSIS OF ACUTE ISCHEMIC STROKE

The search for new methods of diagnosing and treating cerebral stroke that help reduce the medical and social consequences of the disease is one of the priority areas of modern neurology. In recent years, increasing attention has been paid to the use of laboratory methods in the diagnosis of various pathological conditions, which is regarded as a new approach to studying disease pathogenesis. This also applies to newly developed or recently introduced biochemical markers: biologically active proteins that perform specific functions in the nervous system. Matrix metalloproteinases are a family of extracellular proteinases. MMP-2 and MMP-9 degrade extracellular matrix proteins, play an important role in tissue remodeling, and are involved in angiogenesis and in cell proliferation, mi­gration and differentiation.